Literature DB >> 23846384

Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature.

Yasunobu Sekiguchi1, Nana Matsuzawa, Asami Shimada, Hidenori Imai, Mutsumi Wakabayashi, Keiji Sugimoto, Noriko Nakamura, Tomohiro Sawada, Kouji Izutsu, Kengo Takeuchi, Yasunori Ohta, Norio Komatsu, Masaaki Noguchi.   

Abstract

A 65-year-old man was diagnosed with angioimmunoblastic T-cell lymphoma (AITL) with bone marrow (BM) infiltration and myelofibrosis (MF). The BM infiltration and the condition of the MF improved following CHOP therapy (cyclophosphamide hydrate, doxorubicin hydrochloride, vincristine sulfate, and prednisolone). After complete remission was achieved, early central nervous system recurrence was noted, with no evidence of BM infiltration or MF. The lymph nodes and BM were examined for cytokines by immunohistochemical staining with monoclonal murine antibodies. The lymphoma cells were positive only for platelet-derived growth factor (PDGF) and negative for basic fibroblast growth factor, fibronectin, vascular endothelial growth factor, transforming growth factor-β (TGF-β), tumor necrosis factor α, interleukin-1β, and interleukin-6. It was thus inferred that the lymphoma cells producing PDGF caused the MF, and that the absence of MF at relapse may have been attributable to the absence of BM infiltration. There have been seven reported cases of AITL with intercurrent MF, although cytokine data (elevations of blood PDGF and TGFβ levels) are available for only one case. The present report is to our knowledge the only report of a case of AITL complicated by MF for which the results of immunohistostaining with anticytokine antibodies are available.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846384     DOI: 10.1007/s12185-013-1386-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  17 in total

1.  Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta.

Authors:  Y Abe; K Ohshima; M Shiratsuchi; K Honda; J Nishimura; H Nawata; K Muta
Journal:  Eur J Haematol       Date:  2001-03       Impact factor: 2.997

2.  Pure red cell aplasia and myelofibrosis in B-cell neoplasm.

Authors:  Y Hatta; Y Kura; T Yano; H Ushiyama; M Sugitani; T Okano; H Ishizuka; U Sawada; Y Adachi; T Horie
Journal:  J Int Med Res       Date:  2005 Jul-Aug       Impact factor: 1.671

3.  Peripheral T-cell lymphoma together with myelofibrosis with elevated plasma transforming growth factor-beta1.

Authors:  Seiichi Okabe; Keisuke Miyazawa; Tomotaka Iguchi; Masahiko Sumi; Tomoiku Takaku; Yoshikazu Ito; Yukihiko Kimura; Hiromi Serizawa; Kiyoshi Mukai; Kazuma Ohyashiki
Journal:  Leuk Lymphoma       Date:  2005-04

Review 4.  [Reversible myelofibrosis in angioimmunoblastic lymphadenopathy].

Authors:  T Orth; U Treichel; W J Mayet; S Störkel; K H Meyer zum Büschenfelde
Journal:  Dtsch Med Wochenschr       Date:  1994-05-13       Impact factor: 0.628

5.  [An autopsy case of immunoblastic lymphadenopathy associated with pancytopenia and interstitial pneumonitis (author's transl)].

Authors:  M Nishida; T Iwanaga; K Irimajiri; A Horiuchi; S Hashimoto; I Furuta
Journal:  Rinsho Ketsueki       Date:  1981-12

6.  [Angio-immunoblastic lymphadenopathy with fibrosis of bone marrow, lymph node, liver and spleen, and proliferation of epithelioid cells in lymph nodes].

Authors:  I Sato; A Miura; H Yokomichi; C Suzuki; R Ichinohazama
Journal:  Rinsho Ketsueki       Date:  1990-07

7.  Peripheral T-cell lymphoma presenting as myelofibrosis with the expression of basic fibroblast growth factor.

Authors:  Masayuki Kikukawa; Takahiko Umahara; Masayuki Kikawada; Kiyoshi Kanaya; Hirofumi Sakurai; Kouichi Shin; Mayumi Mori; Toshihiko Iwamoto
Journal:  Geriatr Gerontol Int       Date:  2009-12       Impact factor: 2.730

8.  Angioimmunoblastic T cell lymphoma associated with reversible myelofibrosis.

Authors:  Kumiko Matsui; Mayumi Adachi; Takayuki Tominaga; Kenji Shinohara; Toshiaki Kamei
Journal:  Intern Med       Date:  2008-11-04       Impact factor: 1.271

9.  Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma.

Authors:  Karen L Grogg; William G Morice; William R Macon
Journal:  Br J Haematol       Date:  2007-06       Impact factor: 6.998

10.  [Peripheral T-cell lymphoma initially presenting as secondary myelofibrosis].

Authors:  K Takai; M Sanada
Journal:  Rinsho Ketsueki       Date:  1989-12
View more
  5 in total

Review 1.  Primary platelet-derived growth factor-producing, spindle-shaped diffuse large B-cell lymphoma of the skull: a case report and literature review.

Authors:  Kei-Ji Sugimoto; Asami Shimada; Kunimoto Ichikawa; Mutsumi Wakabayashi; Yasunobu Sekiguchi; Hiroshi Izumi; Yasunori Ota; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 2.  Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.

Authors:  Yasunobu Sekiguchi; Syuichi Shirane; Asami Shimada; Kunimoto Ichikawa; Mutsumi Wakabayashi; Keiji Sugimoto; Shigeki Tomita; Hiroshi Izumi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

3.  Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

Authors:  Eiko Ohya; Minoru Mizutani; Haruna Sakaguchi; Takao Sekine
Journal:  Intern Med       Date:  2016-10-01       Impact factor: 1.271

4.  Simultaneous Follicular Lymphoma and Myelofibrosis: Report of a Case with Review of the Literature.

Authors:  Ling-Zhijie Kong; Jing Li; Rui-Cang Wang; Lin Kang; Qiang Wei; Yan Li
Journal:  Onco Targets Ther       Date:  2021-08-24       Impact factor: 4.147

5.  Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis.

Authors:  Hisao Nagoshi; Junya Kuroda; Tsutomu Kobayashi; Saori Maegawa; Yoshiaki Chinen; Miki Kiyota; Ryuko Nakayama; Shinsuke Mizutani; Yuji Shimura; Mio Yamamoto-Sugitani; Yosuke Matsumoto; Shigeo Horiike; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2013-08-15       Impact factor: 2.319

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.